The Patent Finder

Terms ending in 2029

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,298,536Methods of Treating Inflammatory Pain
In force
 · High confidence
Teva Pharmaceuticals International GmbHIn forceHigh confidence
US 9,328,167Methods of Treating Chronic Pain
In force
 · High confidence
Teva Pharmaceuticals International GmbHIn forceHigh confidence
US 10,323,085Methods of Treating Fibromyalgia
In force
 · High confidence
Pfizer LimitedIn forceHigh confidence
US 8,293,239Methods of Treating Chronic Pain
In force
 · High confidence
Teva Pharmaceuticals International GmbHIn forceHigh confidence
US 8,491,915Heat Treated Bacterins, and Emulsion Vaccines Prepared from Such Heat Treated Bacterins
In force
 · High confidence
Zoetis Services LLCIn forceHigh confidence
US 9,221,915Human Monoclonal Antibodies to Activin Receptor-Like KINASE-1
In force
 · High confidence
Amgen Fremont Inc.In forceHigh confidence
US 7,960,515Binding Molecules to the Human OX40 Receptor
In force
 · High confidence
Bristol-Myers Squibb CompanyIn forceHigh confidence
US 7,795,243Penem Prodrugs
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 8,318,208Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 8,912,212Therapeutic Polymeric Nanoparticle Compositions with High Glass Transition Temperature or High Molecular Weight Copolymers
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
21 more term ends in 2029 · Pro
10 of 31 patents shown. Soonest term end first, then patent number.
Pro members see all 31.
Upgrade to Pro
21 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited